IRIS - Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi dell’Insubria.

IRInSubria - Institutional Repository Insubria
IRInSubria raccoglie, conserva, documenta e dissemina le informazioni sulla produzione scientifica dell'Università degli Studi dell’Insubria anche ai fini della valutazione della ricerca.

ANGELI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.252
EU - Europa 10.728
AS - Asia 5.046
SA - Sud America 1.204
AF - Africa 76
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 33.316
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.119
IT - Italia 6.313
SG - Singapore 2.216
UA - Ucraina 1.669
BR - Brasile 1.030
HK - Hong Kong 982
VN - Vietnam 980
IE - Irlanda 744
DE - Germania 604
CN - Cina 498
GB - Regno Unito 414
SE - Svezia 375
RU - Federazione Russa 339
TR - Turchia 86
AR - Argentina 77
FI - Finlandia 62
JP - Giappone 59
IN - India 55
CA - Canada 54
MX - Messico 46
FR - Francia 41
BD - Bangladesh 35
ID - Indonesia 33
EC - Ecuador 29
AT - Austria 28
ES - Italia 24
ZA - Sudafrica 24
PL - Polonia 23
PK - Pakistan 21
CO - Colombia 19
NL - Olanda 18
PY - Paraguay 15
IQ - Iraq 14
MA - Marocco 14
KE - Kenya 12
TT - Trinidad e Tobago 12
UZ - Uzbekistan 12
VE - Venezuela 12
CZ - Repubblica Ceca 11
LT - Lituania 11
SA - Arabia Saudita 10
CH - Svizzera 9
BE - Belgio 8
CL - Cile 8
DO - Repubblica Dominicana 6
EG - Egitto 6
JM - Giamaica 6
RO - Romania 6
TN - Tunisia 6
PE - Perù 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
AU - Australia 4
BO - Bolivia 4
BY - Bielorussia 4
DZ - Algeria 4
GR - Grecia 4
HN - Honduras 4
IL - Israele 4
MY - Malesia 4
PH - Filippine 4
BG - Bulgaria 3
DK - Danimarca 3
ET - Etiopia 3
EU - Europa 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
TW - Taiwan 3
AM - Armenia 2
AZ - Azerbaigian 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
JO - Giordania 2
KH - Cambogia 2
KR - Corea 2
PR - Porto Rico 2
RS - Serbia 2
SN - Senegal 2
AO - Angola 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
EE - Estonia 1
GE - Georgia 1
IR - Iran 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PW - Palau 1
SI - Slovenia 1
Totale 33.314
Salva come PNG Salva come JPEG
Città #
Milan 4.673
Fairfield 2.726
Ashburn 1.965
Woodbridge 1.282
Singapore 1.091
Seattle 1.088
Wilmington 1.033
Houston 1.022
Hong Kong 980
Cambridge 930
Jacksonville 881
Dublin 730
Princeton 646
Rome 454
Dallas 429
Boardman 427
Ann Arbor 398
Chandler 390
Dong Ket 327
Beijing 231
Nyköping 231
San Diego 218
Washington 202
London 146
Los Angeles 146
Ho Chi Minh City 143
The Dalles 142
Chicago 135
Ogden 135
New York 128
São Paulo 78
Hanoi 71
Santa Clara 63
Tokyo 58
Kocaeli 53
Helsinki 48
Council Bluffs 42
Rio de Janeiro 37
Salt Lake City 37
Munich 36
Buffalo 30
Brooklyn 29
Belo Horizonte 27
Como 25
Norwalk 23
Tampa 23
Brasília 22
Nuremberg 22
Prescot 22
San Francisco 22
Des Moines 21
Atlanta 19
Chennai 19
Porto Alegre 19
Kilburn 18
Elk Grove Village 17
Shanghai 17
Treviglio 17
Vienna 17
Warsaw 17
Mexico City 16
Redmond 16
Toronto 16
Johannesburg 15
Stockholm 15
Kunming 14
Montreal 14
Phoenix 14
Boston 13
Chiswick 13
Curitiba 13
Da Nang 13
Haiphong 13
Miami 13
Fortaleza 12
Redwood City 12
Acton 11
Hefei 11
Lancaster 11
Tashkent 11
Thái Bình 11
Wandsworth 11
Amsterdam 10
Asunción 10
Brno 10
Buenos Aires 10
Hounslow 10
Istanbul 10
Nanjing 10
Orem 10
Salvador 10
Southwark 10
Varese 10
Biên Hòa 9
Campinas 9
Charlotte 9
Denver 9
Guarulhos 9
Quito 9
Turin 9
Totale 24.739
Salva come PNG Salva come JPEG
Nome #
Response to Is Vascular Morning Blood Pressure Surge in the Elderly Resistant to Antihypertensives and More Risky? 217
How can we use the results of ambulatory blood pressure monitoring in clinical practice? 191
Optimal Therapy in Hypertensive Subjects with Diabetes Mellitus 187
Circadian rhythm of pulse pressure in hypertension: Prognostic implications 182
Association between periodontal disease and left ventricle mass in essential hypertension 180
The revolution of the anti-diabetic drugs in cardiology 170
Simplifying the ECG Diagnosis of Left Ventricular Hypertrophy 166
Good news for beta-blockers in perioperative medicine 155
Microcirculation and left-ventricular hypertrophy 152
DAY-NIGHT RELATED EVENTS: NIGHTTIME BLOOD PRESSURE FALL AND MORNING BLOOD PRESSURE RISE 148
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus 144
Intensive Blood Pressure Lowering and Regression of Left Ventricular Hypertrophy 143
Adverse prognostic significance of new diabetes in treated hypertensive subjects 143
Fibrillazione atriale e morte cardiaca improvvisa: Un mistero da risolvere? 142
Above Which Blood Pressure Level Does the Risk of Atrial Fibrillation Increase? 140
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke 138
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation-the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study 137
Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview 136
A Risk Score for Predicting 1-Year Mortality in Patients >= 75 Years of Age Presenting With Non-ST-Elevation Acute Coronary Syndrome 136
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 135
Sudden Cardiac Death in Hypertensive Patients 135
Aggressive blood pressure reduction in patients at high vascular risk: Is it dangerous? 129
Hypertension and the J-curve phenomenon: implications for tight blood pressure control 129
Modernization and hypertension: is the link changing? 128
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives 127
Interpretation of Ambulatory Blood Pressure Profile for Risk Stratification Keep It Simple 127
Neutrophil Count for the Identification of Postmenopausal Hypertensive Women at Increased Cardiovascular Risk 127
Additive value of standard ECG for the risk prediction of hypertensive disorders during pregnancy 127
How important is to reduce sodium and increase potassium in patients with hypertension? 125
Ambulatory blood pressure monitoring and prognosis in the management of essential hypertension 125
At the beginning of stiffening - Endothelial dysfunction meets "pulsology" 124
Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve Con Side of the Argument 124
The optimal blood pressure target for patients with coronary artery disease 124
Angiotensin-converting enzyme inhibitors 122
Atrial fibrillation in hypertension - Predictors and outcome 122
Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects 122
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain 122
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome 122
Telmisartan for the reduction of cardiovascular morbidity and mortality 121
Ablation of atrial tachycardia in the setting of prior mitral valve surgery 121
Cardiac Benefits of an Intensive Blood Pressure Control in Diabetes Mellitus 120
The clinical significance of white-coat and masked hypertension 120
What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg? 120
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis 120
Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies 120
Hyperglycemia in acute coronary syndromes: From mechanisms to prognostic implications 120
Pulse pressure affects the relationship between flow-mediated dilatation and cardiovascular risk 119
Aliskiren versus ramipril in hypertension 119
Atrial activation analysis by surface P wave and multipolar esophageal recording after cardioversion of persistent atrial fibrillation 119
Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects 118
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension 118
Neutrophil Count and Ambulatory Pulse Pressure as Predictors of Cardiovascular Adverse Events in Postmenopausal Women with Hypertension 118
Early Invasive Versus Selectively Invasive Strategy in Patients With Non-ST- Segment Elevation Acute Coronary Syndrome: Impact of Age 117
Is Hydrochlorothiazide More Effective on LVH in Nonresponders to Losartan Than in Those to Atenolol? 117
Ambulatory blood pressure for cardiovascular risk stratification 116
Adverse prognostic significance of new diabetes in treated hypertensive subjects 116
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine 116
Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events? 115
White-coat hypertension in adults 115
Response to Role of Yin and Yang in Diurnal Blood Pressure Variation for Cardiovascular Disease 115
Short- and long-term incidence of stroke in white-coat hypertension 115
The emerging role of high-density lipoprotein cholesterol in hypertension trials 115
Left Ventricular Hypertrophy and Coronary Artery Calcifications: A Dangerous Duet? 115
"From Apennines to Andes:" Does Body Mass Index Affect the Relationship Between Age and Blood Pressure? 115
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection 114
Electrocardiographic features of patients with COVID-19 pneumonia 114
PROGNOSTIC VALUE OF URIC ACID IN RELATION TO DIFFERENT AMBULATORY BLOOD PRESSURE COMPONENTS IN THE ABP-INTERNATIONAL STUDY 113
Hypertension, inflammation and atrial fibrillation 113
European and US guidelines for arterial hypertension: similarities and differences 113
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients 113
Improved cardiovascular risk stratification by a simple ECG index in hypertension 113
Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach 113
Blood pressure lowering in diabetic patients 113
Improved performance of traditional ECG for diagnosis of left ventricular hypertrophy in hypertension 113
Estimate of white-coat effect and arterial stiffness 112
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions 112
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials 112
Prognostic value of serial Electrocardiographic voltage and repolarization changes in essential hypertension: The HEART survey study 112
Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement 112
Optimizing the definition of dippers and nondippers: is a 70-86% full glass empty? 112
Electrocardiographic abnormalities of left ventricular repolarization: Prognostic implications in hypertensive post-menopausal women 112
New-onset diabetes in treated hypertensive patients 112
Long-Term Survival in Patients with Post-Operative Atrial Fibrillation after Cardiac Surgery: Analysis from a Prospective Cohort Study 112
Atrial Fibrillation and Mortality in Patients with Acute Myocardial Infarction: A Systematic Overview and Meta-analysis 111
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension Prognostic Implications 111
Prognostic value of lipoprotein fractions in essential hypertension 111
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy 110
Meta-analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension 110
Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis 110
Finding a place for aliskiren in the wide spectrum of blood pressure lowering agents 110
Compared with whom? Addressing the prognostic value of ambulatory blood pressure categories 110
Asymptomatic left ventricular systolic dysfunction in essential hypertension - Prevalence, determinants, and prognostic value 110
Natural history of hypertension subtypes 109
Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy? 109
Clinical usefulness of ambulatory blood pressure monitoring 109
New-onset diabetes, antihypertensive treatment, and outcome 109
Do angiotensin II receptor blockers increase the risk of myocardial infarction? 108
Single and dual blockade of the renin-angiotensin system in high-risk patients without heart failure: Lessons from ONTARGET 108
Response to why is nondipping in ambulatory blood pressure monitoring not prognostic in poor sleepers? 108
Tight Blood Pressure Control in Diabetes: Evidence-Based Review of Treatment Targets in Patients with Diabetes 108
Totale 12.464
Salva come PNG Salva come JPEG
Categoria #
all - tutte 175.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.325
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.387 0 0 0 0 0 1.064 268 634 724 395 419 883
2021/20222.824 269 503 59 87 82 120 182 219 193 442 304 364
2022/20231.998 338 75 81 143 90 508 15 228 242 168 56 54
2023/20247.937 1.109 1.235 1.190 1.475 1.744 767 45 61 198 39 11 63
2024/20254.485 15 41 924 82 79 264 181 167 655 270 402 1.405
2025/20264.255 678 587 683 1.732 512 63 0 0 0 0 0 0
Totale 33.800